TSHA
Taysha Gene Therapies Inc
4.70$
-2.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | +517.5% | -46.1% | +17.3% | |
| – | – | +5,366.7% | +405.5% | -44.9% | -9.2% | -8.0% | |
| – | – | – | – | +102,913.5% | -46.1% | +17.3% | |
| – | +3,131.3% | +313.7% | -30.9% | -37.7% | +16.2% | +30.9% | |
| – | +2,068.0% | +272.3% | -9.6% | -19.6% | -3.6% | +17.0% | |
| – | +3,755.9% | +303.0% | -27.3% | -30.3% | +13.5% | +20.5% | |
| – | – | – | – | – | – | – | |
| – | – | +5,000.0% | +166.0% | +31.6% | -98.0% | -38.2% | |
| – | – | – | – | – | – | – | |
| – | – | – | +281.1% | -66.3% | -7,522.3% | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.